These findings of different preferencesfor peptide sequence properties at cleavage sites of the tau proteinillustrate the differential proteolytic processing mechanisms occurringfor production of synaptic tau peptides in AD and control brain cortex. This evidence concerns the gene MAPT and Alzheimer disease.